iBio, Inc

ACADIA Pharmaceuticals is a biopharmaceutical company utilizing technology to fuel drug discovery and clinical development of treatments for central nervous system disorders. It has five drug programs in clinical and pre-clinical development directed at large unmet medical needs and major commercial markets. ACADIA s three Phase II-stage clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, ACP-103 as an adjunctive therapy for schizophrenia and ACP-104 for treatment of schizophrenia. The company also has clinical and pre-clinical development programs in the areas of neuropathic pain and glaucoma in collaboration with Allergan. ACADIA maintains headquarters and biology research facilities in San Diego and a chemistry research facility in Malmo, Sweden. It trades on NASDAQ under the symbol ACAD.

ACON Laboratories, headquartered in San Diego, California, specializes in providing innovative diagnostic products across various sectors, including point-of-care testing, immunoassays, molecular diagnostics, and animal health. The company is committed to enhancing healthcare through its diverse product lines, which are designed to meet the needs of healthcare professionals and consumers alike. With a focus on quality and reliability, ACON Laboratories offers a range of solutions, including blood glucose monitors, cholesterol testing kits, and veterinary diagnostics. Their commitment to advancing health outcomes is evident in their ongoing development of accessible and effective diagnostic tools for global markets. Generated from the website

Orphagen Pharmaceuticals, located in San Diego, is a leading biopharmaceutical company specializing in innovative drug discovery and development. Their state-of-the-art facilities on Sorrento Valley Rd. are dedicated to advancing cutting-edge research and delivering groundbreaking therapies to improve patient outcomes. Generated from their website's infomation